Dr. Alain Moreau is a Full Professor in the Faculty of Dentistry (Stomatology Department), cross-appointed to the Biochemistry and Molecular Medicine Department in the Faculty of Medicine at Université de Montreal. He served as Director of Research and Chief Scientific Officer of Sainte-Justine University Hospital (2013-2016). Dr. Moreau was the Director of the Network for Canadian Oral Health Research – NCOHR (2016-2022) and he served as member (2010-2022) and vice-president (2012-2016) on the Advisory Board of the Institute of Musculoskeletal Health and Arthritis of The Canadian Institutes of Health Research (CIHR). In 2019, Dr. Moreau was appointed Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network, another national research network funded by CIHR. He is an internationally recognized expert on molecular genetics of pediatric scoliosis. His discoveries led to multiple peer-reviewed papers, international conferences as a guest speaker, several awards as well as 72 patents covering innovative diagnostic tests and therapeutic molecules. Dr. Moreau is the cofounder and Chief Scientific Officer of Inception Therapeutic Inc. a start-up based in Montreal developing diagnostic tests for primary osteoarthritis and new disease-modifying osteoarthritis drugs. Dr. Moreau’s main research interests target pediatric scoliosis and other complex adult diseases such as osteoarthritis, osteoporosis and myalgic encephalomyelitis.


Ouvrir une session

Mot de passe oublié ?

Skip to content